1998
Lymphoid Lesions of the Gastrointestinal Tract: A Histologic, Immunophenotypic, and Genotypic Analysis of 49 Cases
O’Sullivan M, Ritter J, Humphrey P, Wick M. Lymphoid Lesions of the Gastrointestinal Tract: A Histologic, Immunophenotypic, and Genotypic Analysis of 49 Cases. American Journal Of Clinical Pathology 1998, 110: 471-477. PMID: 9763033, DOI: 10.1093/ajcp/110.4.471.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, CDAntigens, CD20Digestive SystemGastrointestinal NeoplasmsGene RearrangementGenotypeHumansImmunoglobulin Heavy ChainsImmunophenotypingKi-67 AntigenLeukemia, Lymphocytic, Chronic, B-CellLeukocyte Common AntigensLeukosialinLymphoid TissueLymphomaLymphoma, Large B-Cell, DiffusePolymerase Chain ReactionSialoglycoproteinsConceptsLymphoid infiltratesMalignant neoplasmsPolymerase chain reactionMalignant lesionsLow-grade malignant neoplasmAvailable diagnostic modalitiesLight microscopic criteriaParaffin-embedded specimensGenotypic analysisGI biopsy specimensConventional microscopic assessmentClinical evidenceClinical outcomesBiopsy specimensLymphoid lesionsCytologic atypiaImmunohistochemical stainsDiagnostic modalitiesGastrointestinal tractMonoclonal bandBenign lesionsDiagnostic standardEnd pointInfiltratesLesions
1994
Overexpression of p53 and HER-2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer
Marks J, Humphrey P, Wu K, Berry D, Bandarenko N, Kerns B, Iglehart J. Overexpression of p53 and HER-2/neu Proteins as Prognostic Markers in Early Stage Breast Cancer. Annals Of Surgery 1994, 219: 332-341. PMID: 7909221, PMCID: PMC1243148, DOI: 10.1097/00000658-199404000-00002.Peer-Reviewed Original ResearchConceptsHER-2/neuEarly-stage breast cancerStage breast cancerHER-2/neu oncogeneBreast cancerPrognostic valueHER-2/neu proteinNeu oncogeneGenetic abnormalitiesDuke University Medical CenterFailure-free survivalProgesterone receptor contentCohort of patientsLimited prognostic valueIndependent prognostic valueShorter survival timeParaffin-embedded specimensUniversity Medical CenterHER-2/neu geneOverexpression of p53Common genetic abnormalityNodal statusRetrospective cohortLow estrogenTumor size